These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 212898)

  • 21. [Rhodopsin fluorescence in the retinal rods of the bull at -196 degrees C].
    Sineshchekov VA; Litvin FF
    Dokl Akad Nauk SSSR; 1985; 281(6):1471-4. PubMed ID: 4028929
    [No Abstract]   [Full Text] [Related]  

  • 22. Ascorbic acid inhibition of cyclic nucleotide phosphodiesterase acitivity.
    Malamud D; Kroll Y
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):534-6. PubMed ID: 6251481
    [No Abstract]   [Full Text] [Related]  

  • 23. Rhodopsin phosphorylation in developing normal and degenerative mouse retinas.
    Shuster TA; Farber DB
    Invest Ophthalmol Vis Sci; 1986 Feb; 27(2):264-8. PubMed ID: 3003003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activity of cyclic nucleotide phosphodiesterase in rod outer segments of the gopher retina].
    Orlov NIa; Kalinin EV; Orlova TG; Freĭdin AA; Ivanitskiĭ GR
    Dokl Akad Nauk SSSR; 1986; 286(2):454-7. PubMed ID: 3004869
    [No Abstract]   [Full Text] [Related]  

  • 25. Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma.
    Raeburn D; Souness JE; Tomkinson A; Karlsson JA
    Prog Drug Res; 1993; 40():9-32. PubMed ID: 8395068
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.
    Beavo JA; Reifsnyder DH
    Trends Pharmacol Sci; 1990 Apr; 11(4):150-5. PubMed ID: 2159198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunocytochemical colocalization of clusterin in apoptotic photoreceptor cells in retinal degeneration slow rds mutant mouse retinas.
    Agarwal N; Jomary C; Jones SE; O'Rourke K; Chaitin M; Wordinger RJ; Murphy BF
    Biochem Biophys Res Commun; 1996 Aug; 225(1):84-91. PubMed ID: 8769098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of 2',3'-cyclic nucleotide 3'-phosphodiesterase activity from bovine, human and guinea pig brain.
    Sprinkle TJ; Knerr JR
    Brain Res; 1981 Jun; 214(2):455-9. PubMed ID: 6263423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and biochemical changes in vitamin A--deficient rat retinas.
    Carter-Dawson L; Kuwabara T; O'Brien PJ; Bieri JG
    Invest Ophthalmol Vis Sci; 1979 May; 18(5):437-46. PubMed ID: 437947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous inhibition of guinea pig brain 2',3'-cyclic nucleotide 3'-phosphohydrolase and myelin protein synthesis by 2'-adenosine monophosphate.
    Starich GH; Dreiling CE
    Life Sci; 1980 Aug; 27(7):567-72. PubMed ID: 6252405
    [No Abstract]   [Full Text] [Related]  

  • 31. Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: evaluation of structure-activity relationships.
    Wu PH; Phillis JW; Nye MJ
    Life Sci; 1982 Dec; 31(25):2857-67. PubMed ID: 6298531
    [No Abstract]   [Full Text] [Related]  

  • 32. P23H and S334ter opsin mutations: Increasing photoreceptor outer segment n-3 fatty acid content does not affect the course of retinal degeneration.
    Martin RE; Ranchon-Cole I; Brush RS; Williamson CR; Hopkins SA; Li F; Anderson RE
    Mol Vis; 2004 Mar; 10():199-207. PubMed ID: 15064683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
    Raeburn D; Karlsson JA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fatty acid composition of the bilayer phospholipids in the photoreceptor membranes and aminophospholipids from the rhodopsin microenvironment of warm-blooded and cold-blooded vertebrates].
    Tiurin VA; Berman AL; Rychkova MP; Chelomin VP; Korchagin VP
    Zh Evol Biokhim Fiziol; 1982; 18(1):101-4. PubMed ID: 6979137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of phosphodiesterase isozyme contribution in cell and tissue extracts.
    Keravis T; Thaseldar-Roumié R; Lugnier C
    Methods Mol Biol; 2005; 307():63-74. PubMed ID: 15988055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of flavonoids on cyclic nucleotide phosphodiesterases.
    Beretz A; Anton R; Cazenave JP
    Prog Clin Biol Res; 1986; 213():281-96. PubMed ID: 3012580
    [No Abstract]   [Full Text] [Related]  

  • 37. [Utilization of a multiparametric technique for analysis of specificity of different inhibitors of various forms of cyclic nucleotide phosphodiesterases].
    Lugnier C; Doré JC; Stoclet JC; Viel C
    Pharmazie; 1992 Jan; 47(1):46-9. PubMed ID: 1319070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
    Drees M; Zimmermann R; Eisenbrand G
    Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic nucleotide phosphodiesterases in the circulatory system. Biochemical, pharmacological, and functional characteristics.
    Weishaar RE; Kobylarz-Singer D; Keiser JA; Wright CD; Cornicelli J; Panek R
    Adv Second Messenger Phosphoprotein Res; 1992; 25():249-69. PubMed ID: 1313261
    [No Abstract]   [Full Text] [Related]  

  • 40. [Participation of the estradiol receptor in the hormonal inhibition of cyclic nucleotide phosphodiesterase in the uterus].
    Garnovskaia MN; Dumler IL
    Ukr Biokhim Zh (1978); 1984; 56(6):633-7. PubMed ID: 6096994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.